Conv. Plasma
Nigella Sativa

All zinc studies
Meta analysis
study COVID-19 treatment researchZincZinc (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Low serum levels of zinc and 25-hydroxyvitmain D as potential risk factors for COVID-19 susceptibility: a pilot case-control study

Ghanei et al., European Journal of Clinical Nutrition, doi:10.1038/s41430-022-01095-5
Mar 2022  
  Source   PDF   All Studies   Meta AnalysisMeta
Zinc for COVID-19
2nd treatment shown to reduce risk in July 2020
*, now known with p = 0.0000027 from 43 studies, recognized in 10 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
3,900+ studies for 60+ treatments.
Case control study with 90 COVID-19 cases and 95 matched controls in Iran, showing significantly lower zinc levels for cases.
Study covers vitamin D and zinc.
Ghanei et al., 23 Mar 2022, prospective, Iran, peer-reviewed, 6 authors, study period 20 March, 2020 - 20 January, 2021.
This PaperZincAll
Low serum levels of zinc and 25-hydroxyvitmain D as potential risk factors for COVID-19 susceptibility: a pilot case-control study
Esmat Ghanei, Moein Baghani, Hamideh Moravvej, Atefeh Talebi, Ayda Bahmanjahromi, Fahimeh Abdollahimajd
European Journal of Clinical Nutrition, doi:10.1038/s41430-022-01095-5
BACKGROUND AND AIMS: This study aimed to evaluate serum 25-hydroxyvitmain D and zinc levels in coronavirus disease 2019 patients in comparison to healthy subjects. METHODS: This was a single-center case-control study performed from March 20, 2020, to January 20, 2021, in Tehran, Iran. All patients diagnosed with COVID-19 based on a positive nasopharyngeal swab polymerase chain reaction (PCR) test were included in the case group. Controls were selected from patients referred for routine checkups who had a negative COVID-19 PCR test. Age, sex, marital and educational status, comorbidities, and serum 25-hydroxyvitmain D and zinc levels of patients were recorded. RESULTS: Ninety patients in the case group and 95 subjects in the control group who were sex and age-matched were studied. 25hydroxyvitmain D levels higher than 20 ng/ml were observed in 58 (64%) cases and 72 (76%) controls (P = 0.09). The median 25hydroxyvitmain D level in the case group was significantly lower than controls (26 (interquartile range [IQR] = 24) ng/ml vs. 38 (IQR = 22) ng/ml, respectively, P < 0.01). The median zinc level in the case group was 56 (IQR = 23) mcg/dL, while it was 110 (IQR = 27) mcg/dL among the controls (P < 0.01). There was no significant difference in the level of 25-hydroxyvitmain D and zinc between cases with and without comorbidities (P > 0.05). Susceptibility to SARS-CoV-2 infection could be predicted by serum 25hydroxyvitmain D levels below 25.2 ng/ml (81% sensitivity; 48% specificity) or zinc levels below 86.3 mcg/dL (93% sensitivity; 92% specificity). CONCLUSIONS: Low serum zinc and 25-hydroxyvitmain D levels appear to be risk factors for COVID-19 affliction; thus, the treatment of individuals with such deficiencies is recommended.
AUTHOR CONTRIBUTIONS EG and FA contributed to the conception of the work. HM, EG, MB, AB and FA contributed to the acquisition of data and AT contributed to the analysis, and interpretation of data for the work. AB, MB and FA drafted the manuscript. FA and EG and HM critically revised the manuscript. All authors gave final approval and agreed to be accountable for all aspects of the work ensuring integrity and accuracy. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. COMPETING INTERESTS The authors declare no competing interests. ETHICAL APPROVAL The study protocol was approved by our institute's Ethics Committee in Biomedical Research with reference code IR.SBMU.SRC.REC.1399.007. ADDITIONAL INFORMATION Supplementary information The online version contains supplementary material available at Correspondence and requests for materials should be addressed to Ayda bahmanjahromi or Fahimeh Abdollahimajd. Reprints and permission information is available at reprints Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Berg, Bolt, Andersen, Owen, Zinc potentiates the antiviral action of human IFN-α tenfold, J Interferon Cytokines Res
Biesalski, Vitamin D deficiency and co-morbidities in COVID-19 patients-A fatal relationship?, NFS J
Buyukuslu, Esin, Hizli, Sunal, Yigit et al., Clothing preference affects vitamin D status of young women, Nutr Res
Calder, Carr, Gombart, Eggersdorfer, Optimal nutritional status for a well-functioning immune system is an important factor to protect against viral infections, Nutrients
Carlucci, Ahuja, Petrilli, Rajagopalan, Jones et al., Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients, J Med Microbiol
Carr, Micronutrient status of COVID-19 patients: a critical consideration, Crit Care
D'avolio, Avataneo, Manca, Cusato, Nicolò et al., 25-hydroxyvitmain D concentrations are lower in patients with positive PCR for SARS-CoV-2, Nutrients
Daneshkhah, Agrawal, Eshein, Subramanian, Roy et al., Evidence for possible association of vitamin D status with cytokine storm and unregulated inflammation in COVID-19 patients, Aging Clin Exp Res
Dankers, Colin, Van Hamburg, Lubberts, Vitamin D in autoimmunity: molecular mechanisms and therapeutic potential, Front Immunol
Darling, Ahmadi, Ward, Harvey, Alves et al., Vitamin D status, body mass index, ethnicity and COVID-19: initial analysis of the first
Gasmi, Noor, Tippairote, Dadar, Menzel et al., Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic, Clin Immunol
Gasmi, Tippairote, Mujawdiya, Peana, Menzel et al., Micronutrients as immunomodulatory tools for COVID-19 management, Clin Immunol
Ghazi, Zadeh, Pezeshk, Azizi, Cacicedo, Seasonal variation of serum 25 hydroxy D3 in residents of Tehran, J Endocrinol Invest
Giannini, Passeri, Tripepi, Sella, Fusaro et al., Effectiveness of in-hospital cholecalciferol use on clinical outcomes in comorbid COVID-19 patients: a hypothesis-generating study, Nutrients
Gombart, Borregaard, Koeffler, Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly upregulated in myeloid cells by 1, 25-dihydroxyvitamin D3, FASEB
Gorji, Ghadiri, Potential roles of micronutrient deficiency and immune system dysfunction in the coronavirus disease 2019 (COVID-19) pandemic, Nutrition
Grant, Lordan, Vitamin D for COVID-19 on trial: An update on prevention and therapeutic application, Endocr Pract
Greiller, Martineau, Modulation of the immune response to respiratory viruses by vitamin D, Nutrients
Gröber, Holick, The coronavirus disease (COVID-19)-A supportive approach with selected micronutrients, Int J Vitam Nutr Res
Han, Chang, Juo, Lee, Yeh et al., Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): expression, purification, characterization, and inhibition, Biochem
Holick, Binkley, Bischoff-Ferrari, Gordon, Hanley et al., Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab
Hurst, Mellanby, Handel, Griffith, Rossi et al., Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a crosssectional study, BMJ
Ilie, Stefanescu, Smith, The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality, Aging Clin Exp Res
Infante, Ricordi, Sanchez, Salzler, Padilla et al., Influence of vitamin D on islet autoimmunity and beta-cell function in type 1 diabetes, Nutrients
Jothimani, Kailasam, Danielraj, Nallathambi, Ramachandran et al., COVID-19: Poor outcomes in patients with zinc deficiency, Int J Infect Dis
Junaid, Ejaz, Abdalla, Abosalif, Ullah et al., Effective immune functions of micronutrients against SARS-CoV-2, Nutrients
Khalighi, Jahangirimehr, Labibzadeh, Bahmanyari, Najafi et al., Calcium, and Zinc Levels Patients with COVID-19, Clin Nutr ESPEN
Larijani, Tehrani, Hamidi, Soltani, Pajouhi, Osteoporosis, global and Iranian aspects, Iran J Public Health
Lordan, Notable developments for vitamin D amid the COVID-19 pandemic, but caution warranted overall: A narrative review, Nutrients
Lordan, Rando, Greene, Dietary supplements and nutraceuticals under investigation for COVID-19 prevention and treatment, Msystems
Maghbooli, Sahraian, Jamali-Moghadam, Asadi, Zendehdel et al., Treatment with 25-hydroxyvitamin D3 (calcifediol) is associated with a reduction in the blood neutrophil-to-lymphocyte ratio marker of disease severity in patients hospitalized with COVID-19: a pilot, multicenter, randomized, placebocontrolled double blind clinical trial, Endocr Pract
Mcauliffe, Ray, Fallon, Bradfield, Eden et al., Dietary micronutrients in the wake of COVID-19: an appraisal of evidence with a focus on highrisk groups and preventative healthcare, BMJ Nutr Prev Health
Meltzer, Best, Zhang, Vokes, Arora et al., Association of vitamin D status and other clinical characteristics with COVID-19 test results, JAMA
Mendes, Charlton, Thakur, Ribeiro, Lanham-New et al., Future perspectives in addressing the global issue of vitamin D deficiency, Proc Nutr Soc
Muszkat, Camargo, Griz, Lazaretti-Castro, Evidence-based nonskeletal actions of vitamin D, Arq Bras Endocrinol Metab
Orces, The association between body mass index and vitamin D supplement use among adults in the United States, Cureus
Pecora, Persico, Argentiero, Neglia, Esposito, The role of micronutrients in support of the immune response against viral infections, Nutrients
Pinzon, Pradana, Vitamin D deficiency among patients with COVID-19: case series and recent literature review, Trop Med Health
Richardson, Lovegrove, Nutritional status of micronutrients as a possible and modifiable risk factor for COVID-19: a UK perspective, Brit J Nutr
Rios-Lugo, Madrigal-Arellano, Gaytán-Hernández, Hernández-Mendoza, Romero-Guzmán, Association of serum zinc levels in overweight and obesity, Biol Trace Elem Res
Smet, Smet, Herroelen, Gryspeerdt, Martens, Vitamin D deficiency as risk factor for severe COVID-19: a convergence of two pandemics
Souza, Vasconcelos, Prado, Pereira, Zinc, Vitamin D and Vitamin C: perspectives for COVID-19 with a focus on physical tissue barrier integrity, Front Nutr
Tang, Wang, Gao, The short form of the zinc finger antiviral protein inhibits influenza A virus protein expression and is antagonized by the virus-encoded NS1, J Virol
Tellinghuisen, Marcotrigiano, Rice, Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase, Nature
Thomas, Patel, Bittel, Wolski, Wang et al., Effect of high-dose zinc and ascorbic acid supplementation vs usual care on symptom length and reduction among ambulatory patients with SARS-CoV-2 infection: the COVID A to Z randomized clinical trial, JAMA Netw Open
Wang, Dabbas, Laperriere, Bitton, Soualhine et al., Direct and indirect induction by 1, 25-dihydroxyvitamin D3 of the NOD2/ CARD15-defensin β2 innate immune pathway defective in Crohn disease, J Biol Chem
Wessels, Rolles, Rink, The potential impact of zinc supplementation on COVID-19 pathogenesis, Front Immunol
Yao, Paguio, Dee, Tan, Moulick et al., The minimal effect of zinc on the survival of hospitalized patients with COVID-19: an observational study, Chest
Zhu, Zhang, Li, Yang, Song, A novel coronavirus from patients with pneumonia in China, 2019, N Engl J Med
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop